📈 Hemas Holdings Marks Milestone Year with Record FY25/26 Earnings

Hemas Holdings PLC achieved historic milestone earnings for FY2025/26, driven by recovering consumer demand, healthcare expansion, and strong maritime performance. Overall Financial Highlights • Full-Year Net Profit: Rs. 8.92 Bn (↑ 10.7% YoY). 4Q earnings reached Rs. 3.03 Bn (↑ 17.6% YoY). • Group Revenue: Rs. 127.4 Bn (↑ 8.0% YoY), with growth across all three core business units. • Profit Margins: Gross profit margin expanded by 110 bps, though EBITDA and EBIT margins compressed by 40 bps and 50 bps due to aggressive digital and infrastructure reinvestments. • Future Strategy: Over US$ 100 Mn earmarked for investments over the next 4 years. Planned FY27 acquisitions aim to boost international revenue from 3% to 10%. Sector Breakdowns • Consumer Brands: Revenue up 2.2% YoY; earnings up 6.5% YoY. Sri Lankan Home and Personal Care volumes grew 4.2%, led by a 12.2% surge in Beauty. Bangladesh operations transitioned to profitability, growing value by 14.5% YoY. Atlas maintained market leadership with 6.1% volume growth. • Healthcare: Revenue increased 11.5% YoY; earnings jumped 14.2% YoY. Pharmaceutical manufacturing (Morison) logged 18.6% volume growth, with its diabetes brand EmpaMor securing market leadership. Hospitals revenue spiked 24.0% YoY, supported by expansion at the Wattala facility. • Mobility: Revenue grew 17.8% YoY; earnings up 6.1% YoY. Evergreen shipping expanded market share amid a 9.0% regional throughput growth, while Emirates sustained air cargo market leadership.